RxDoctor Payments Data

Richard Perrin, MD

Neurological Surgery · Anchorage, AKNPI 1225140312

Payments from drug & device makers

What this record shows

17 manufacturers reported payments, led by Medtronic at 24.5% of the total.

$15,445in general payments, 2019–2025

Across 153 payments — averaging $100.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Globus Medical$3K
  • Medical Device Business Services, Inc.$3K
  • Abbott$3K
  • Si-bone, Inc.$1K
  • Johnson & Johnson$1K
  • plus $1K from 11 others

What the payments were for

  • Travel & lodging$8,88858%
  • Food & beverage$6,55842%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)31$3,779
Globus Medical(2 entities)25$2,818
Medical Device Business Services, Inc.10$2,555
Abbott20$2,547
Si-bone, Inc.10$1,257
Johnson & Johnson27$1,158
Nevro Corp.14$438
Cerapedics Inc.3$236
Innovation Technologies Inc2$222
Centinel Spine, LLC2$139
AbbVie2$93
Baxter Healthcare1$73
Stryker1$55
Chiesi USA, Inc.1$23
BK Medical Holding Company Inc.1$20
GT Medical Technologies, Inc2$19
Avanos Medical1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few neurological surgery providers in Alaskato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$291,827
Medicare patients
155
Services billed
597

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Zonisamide13$126

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Anchorage

See the full list for Alaska

Where these figures come from

Is this you, or does something look wrong? →